Autoantibodies against protective molecules - C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: Prevalence in systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 227-239

  Shoenfeld, Yehuda ^a,b   Szyper Kravitz, Martine ^a,b   Witte, Torsten ^c   Doria, Andrea ^d   Tsutsumi, Akito ^e   Tatsuya, Abe ^e,f   Dayer, Jean Michel ^f   Roux Lombard, Pascale ^f   Fontao, Lionel ^f   Kallenberg, Cees G M ^g   Bijl, Marc ^g   Matthias, Torsten ^h   Fraser, Abigail ⁱ   Zandman Goddard, Gisele ^b,j   Blank, Miri ^a,b   Gilburd, Boris ^a,b   Meroni, Pier Luigi ^k,l  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h Aesku Lab Diagnostika   (Germany)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j WOLFSON MEDICAL CENTER   (Israel)

^k UNIVERSITY OF MILAN   (Italy)

^l ISTITUTO AUXOLOGICO ITALIANO   (Italy)

more..

Author keywords

Anti APO A1; Anti C1q; Anti CRP; Anti MBL; Anti SAP; Apoptosis; Autoantibodies; SLE

Indexed keywords

APOLIPOPROTEIN A1 ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN ANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; MANNOSE BINDING LECTIN ANTIBODY; SERUM AMYLOID P ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; AUTOIMMUNITY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; POPULATION RESEARCH; PREVALENCE; SCREENING TEST; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34948862783     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.025     Document Type: Conference Paper

References (47)

1. SHERER, Y., A. GORSTEIN, M.J. FRITZLER & Y. SHOENFELD. 2004. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin. Arthritis Rheum. 34: 501-537.
2. TISHLER, M. & Y. SHOENFELD. 2004. Vaccination may be associated with autoimmune diseases. Isr. Med. Assoc. J. 6: 430-432.
3. BACH, J.F. 2002. The effects of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
4. YOON, J.W. 1990. The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 164: 95-123.
5. AMITAL, H. & Y. SHOENFELD. 2004. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In Systemic Lupus Erythematosus, 4th ed. Robert G. Lahita, Ed.: 1-16. Elsevier Publication. Amsterdam.
6. SHOENFELD, Y. & D.A. ISENBERG. 1989. The Mosaic of Autoimmunity. Immunol. Today 10: 123-126.
7. SHOENFELD, Y. & D.A. ISENBERG. 1989. The Mosaic of Autoimmunity. Elsevier Publication. Amsterdam.
8. MEVORACH, D., J.L. ZHOU, X. SONG & K.B. ELKON. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188: 387-392.
9. KALDEN, J. 2004. Apoptosis in systemic autoimmunity. Autoimmun. Rev. 3: S9-S10.
10. NAUTA, A.J., M.R. DAHA, C. KOOTERN & A. ROOS. 2003. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 24: 148-153.
11. SONTHEIMER, R.D., E. RACILA, & D.M. RACILA. 2005. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J. Invest. Dermatol. 125: 14-23.
12. TURNER, M.W. 2003. The role of mannose-binding lectin in health and disease. Mol. Immunol. 40: 423-429.
13. GERSHOV, D., S.J. KIM, N. BROT & K.B. ELKON. 2000. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustain anti-inflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192: 1353-1363.
14. FAMILIAN, A., B. ZWART, H.G. HUISMAN, et al. 2001. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 167: 647-654.
15. EMSLEY, J., H.E. WHITE, B.P. O'HARA, et al. 1994. Structure of pentameric human serum amyloid P component. Nature 367: 338-345.
16. DU CLOS, T.W. 2004. Function of C-reactive protein. Ann. Med. 32: 274-278.
17. SAEVARSDOTTIR, S., T. VIKINGSDOTTIR & H. VALDIMARSSON. 2004. The potential role of mannan-binding lectin in the clearance of self-components including immune complexes. Scand. J. Immunol. 60: 23-29.
18. BURGER, D. & J.M. DAYER. 2002. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun. Rev. 1: 111-117.
19. BICKERSTAFF, M.C.M., M. BOTTO, W. HUTCHINSON, et al. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5: 694-697.
20. DUCLOS, T.W., L. ZLOCK, P.S. HICKS & C. MOLD. 1994. Decreased autoantibody levels and enhanced survival of (NZB X NZW) F1 mice treated with C-reactive protein. Clin. Immunol. Immunopath. 70: 22-27.
21. SZALAI, A.J., C.T. VER WEA, M.A. MCCRORY, et al. 2003. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum. 48: 1602-1611.
22. RODRIGUEZ, W., C. MOLD, M. KATAVANOVSKI, et al. 2005. Reversal of ongoing proteinuria in autoimmune mice by treatment with CRP. Arthritis Rheum. 52: 642-650.
23. PEPYS, M.B., J.G. LANHAM & F.C. DE BEER. 1982. C-reactive protein in SLE. Clin. Rheum. Dis. 8: 91-103.
24. ZANDMAN-GODDARD, G., M. BLANK, P. LANGEVITZ, et al. 2005. Anti-serum amyloid P (SAP) antibodies in SLE patients correlate with disease activity. Ann. Rheum. Dis. 64: 1698-1702.
25. TAN, E.M., A.S. COHEN, J.F. FREIS, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
26. VITALI, C., W. BENCIVELLI, D.A. ISENBERG, et al. 1992. Identification of the variables indicative of disease activity and their use in the development of an activity score. European Consensus Study Group for Disease Activity in SLE. Clin. Exp. Rheumatol. 10: 541-547.
27. BOMBARDIER, C., D.D. GLADMAN, M.B. UROWITZ, D. CARON, C.H. CHANG & THE COMMITTEE ON PROGNOSIS STUDIES IN SLE. 1992. Derivation of the SLEDAI. Arthritis Rheum. 35: 630-640.
28. TAKAHASHI, R., A. TSUTSUMI, K. OHTANI, et al. 2004. Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin. Exp. Immunol. 136: 585-590.
29. OHTANI, K., Y. SUZUKI, S. EDA, et al. 1999. High-level and effective production of human mannan-binding lectin (MBL) in Chinese hamster ovary(CHO) cells. J. Immunol. Methods 222: 135-144.
30. VUILLEUMIER, N., G. REBER, R. JAMES, et al. 2004. Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease. J. Autoimmun. 23: 353-360.
31. FRANZ, S., U.S. GAIPL, L.E. MUNOZ, et al. 2006. Apoptosis and autoimmunity: when apoptotic cells break their silence. Curr. Rheumatol. Rep. 8: 245-247.
32. COOK, H.T. & M. BOTTO. 2006. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 330-337.
33. GAIPL, U.S., R.E. VOLL, A. SHERIFF, et al. 2005. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun. Rev. 4: 189-194.
34. BELL, S.A., H. FAUST, A. SCHMID & M. MEURER. 1998. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic lupus erythematosus. Clin. Exp. Immunol. 113: 327-332.
35. SJOWALL, C., P. ERIKSSON, S. ALMER & T. SKOGH. 2002. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren syndrome, rheumatoid arthritis or inflammatory bowel disease. J. Autoimmun. 19: 155-160.
36. SJOWALL, C., A.A. BENGTSSON, G. STURFEL & T. KOGH. 2004. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res. Ther. 6: R87-R94.
37. MOK, M.Y., D.L. JACK, C.S. LAU, et al. 2004. Antibodies to mannose binding lectin in patients with systemic lupus erythematosus. Lupus 13: 522-528.
38. SEELEN, M.A., L.A. TROUW, J.W. VAN DER HOORN, et al. 2003. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin. Exp. Immunol. 134: 335-343.
39. TAKAHASHI, R., A. TSUTSUMI, K. OHTANI, et al. 2004. Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin. Exp. Immunol. 36: 585-590.
40. TSUTSUMI, A., R. TAKAHASHI & T. SUMIDA. 2005. Mannose binding lectin: genetics and autoimmune disease. Autoimmun. Rev. 4: 364-372.
41. ABE, H., N. TSUBOI, S. SUZUKI, et al. 2001. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus. J. Rheumatol. 28: 990-995.
42. DINU, A.R., J.T. MERRILL, C. SHEN, et al. 1998. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus 7: 355-360.
43. DELGADO ALVES, J., S. KUMAR & D.A. ISENBERG. 2003. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxf). 42: 893-899.
44. TRENDELENBURG, M. 2005. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin. Immunopathol. 27: 276-285.
45. SINICO, R.A., A. RADICE, M. IKEHATA, et al. 2005. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann. N.Y. Acad. Sci. 1050: 193-200.
46. MARTO, N., M.L. BERTOLACCINI, E. CALABUIG, G.R. HUGHES & M.A. KHAMASHTA. 2005. Anti-C1q antibodies in nephritis: correlation between titers and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 64: 444-448.
47. SZYPER-KRAVITZ, M. & Y. SHOENFELD. 2006. Autoimmunity to protective molecules - is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases? Nat. Clin. Pract. Rheumatol. 2: 481-490.